RE: Good luck14 Sep 2020 16:33
Im not sure what happened. In Septmber 2017 the share price started to spike. Ironically it appears to be in anticipation of Lupuzor results.
In Feb 2018 a placing at 140 raised 10m. Dare I give Tim the benefit of the doubt? Tim by trade is an accountant. He will rely on his clinical advisors. If he had been advised that the trial of Lupuzor were looking good, he would have passed that onto the investors. The rest is history
The share price held firmish until April 2018 when II's offloaded their shares at around 160. The value fell to the 40s.
This time things are different. He has convinced Avion to sponsor the SPA. Avion would have crawled over any data IMM had and they are prepared to back Lupuzor.